Your browser doesn't support javascript.
loading
Small Intestinal Bacterial Overgrowth: Nutritional Implications, Diagnosis, and Management.
Adike, Abimbola; DiBaise, John K.
Afiliação
  • Adike A; Division of Gastroenterology and Hepatology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA.
  • DiBaise JK; Division of Gastroenterology and Hepatology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA. Electronic address: dibaise.john@mayo.edu.
Gastroenterol Clin North Am ; 47(1): 193-208, 2018 Mar.
Article em En | MEDLINE | ID: mdl-29413012
ABSTRACT
Small intestinal bacterial overgrowth (SIBO), characterized by the presence of excessive bacteria in the small intestine, is typically described as a malabsorptive syndrome occurring in the context of gut stasis syndromes. SIBO is now considered to be a disorder associated with diverse clinical conditions without classic risk factors for SIBO and a cause of several nonspecific gastrointestinal and nongastrointestinal symptoms. Because there is currently no gold standard for diagnosing SIBO, its prevalence and role in the pathogenesis of other diseases remain uncertain; as does optimal treatment of patients with relapsing symptoms.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome da Alça Cega / Microbioma Gastrointestinal Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Gastroenterol Clin North Am Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome da Alça Cega / Microbioma Gastrointestinal Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Gastroenterol Clin North Am Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos